Home > National Drug Code (NDC) > RINKEL MOLD MIX B

RINKEL MOLD MIX B - 54575-229-20 - (trichothecium roseum and passalora fulva and cochliobolus spicifer and myrothecium verrucaria and trichophyton schoenleinii and mycogone nigra and neurospora crassa and khuskia oryzae and paecilomyces)

Alphabetical Index


Drug Information of RINKEL MOLD MIX B

Product NDC: 54575-229
Proprietary Name: RINKEL MOLD MIX B
Non Proprietary Name: trichothecium roseum and passalora fulva and cochliobolus spicifer and myrothecium verrucaria and trichophyton schoenleinii and mycogone nigra and neurospora crassa and khuskia oryzae and paecilomyces
Active Ingredient(s): .071; .072; .071; .072; .071; .071; .071; .072; .071; .072; .072; .072; .071; .071    g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL & nbsp;   trichothecium roseum and passalora fulva and cochliobolus spicifer and myrothecium verrucaria and trichophyton schoenleinii and mycogone nigra and neurospora crassa and khuskia oryzae and paecilomyces
Administration Route(s): PERCUTANEOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of RINKEL MOLD MIX B

Product NDC: 54575-229
Labeler Name: Allergy Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA101376
Marketing Category: BLA
Start Marketing Date: 19671207

Package Information of RINKEL MOLD MIX B

Package NDC: 54575-229-20
Package Description: 2 mL in 1 VIAL, MULTI-DOSE (54575-229-20)

NDC Information of RINKEL MOLD MIX B

NDC Code 54575-229-20
Proprietary Name RINKEL MOLD MIX B
Package Description 2 mL in 1 VIAL, MULTI-DOSE (54575-229-20)
Product NDC 54575-229
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name trichothecium roseum and passalora fulva and cochliobolus spicifer and myrothecium verrucaria and trichophyton schoenleinii and mycogone nigra and neurospora crassa and khuskia oryzae and paecilomyces
Dosage Form Name INJECTION, SOLUTION
Route Name PERCUTANEOUS; SUBCUTANEOUS
Start Marketing Date 19671207
Marketing Category Name BLA
Labeler Name Allergy Laboratories, Inc.
Substance Name COCHLIOBOLUS SPICIFER; HELMINTHOSPORIUM SOLANI; KHUSKIA ORYZAE; MICROASCUS BREVICAULIS; MYCOGONE NIGRA; MYROTHECIUM VERRUCARIA; NEUROSPORA CRASSA; PAECILOMYCES VARIOTII; PASSALORA FULVA; PLEOSPORA TARDA; STREPTOMYCES GRISEUS; TRICHODERMA VIRIDE; TRICHOPHYTON SCHOENLEINII; TRICHOTHECIUM ROSEUM
Strength Number .071; .072; .071; .072; .071; .071; .071; .072; .071; .072; .072; .072; .071; .071
Strength Unit g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL
Pharmaceutical Classes Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Bacterial Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Bacterial Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of RINKEL MOLD MIX B


General Information